Cancer is a grievous disease whose treatment requires a more efficient, non-invasive
therapy, associated with minimal side effects. Gold nanoparticles possessing greatly …

Alzheimer's disease (AD) is a progressive neurodegenerative disorder that accounts for
more than half of all dementia cases in the elderly. Interestingly, the clinical manifestations of …

Alzheimer's disease (AD) is the most common neurological disease and a serious cause of
dementia, which constitutes a threat to human health. The clinical evidence has found that …

For specific targeting of cancer tissues, adequate information about the cancer tissue
environment, cancer cell pathology, and available methods and limits of such methods is …

Autophagy is a cellular degradation system that recycles or degrades damaged organelles,
viral particles, and aggregated proteins through the lysosomal pathway. Autophagy plays an …

The quest for effective and reliable methods of delivering medications, with the aim of
improving delivery of therapeutic agent to the intended location, has presented a demanding …

MicroRNA (miRNA) is involved in the progression of Alzheimer's disease (AD) and emerges
as a promising AD biomarker and therapeutic target. Therefore, there is an urgent need to …

Ethnopharmacological relevance This review explores the link between Type 2 Diabetes
Mellitus (T2DM) and diabetes-induced Alzheimer's disease (AD). It emphasizes the shared …

Alzheimer's disease, a prevalent form of dementia affecting millions worldwide, poses a
significant challenge, especially in elderly females after postmenopausal. The delivery of …

阿尔茨海默症（ AD） 是一种以认知障碍为特征的神经退行性疾病， 其主要临床表现是空间工作
记忆（ SWM） 障碍， 严重影响患者身心健康， 而现有药物疗法存在治愈率低等问题 …